Initial Management of New Onset Diabetes Mellitus

Immediate Initial Evaluation

The American Diabetes Association recommends a complete medical evaluation at the initial visit to classify the diabetes type, detect complications, and formulate an individualized management plan that includes diabetes self-management education and a collaborative care team 1
Classify the diabetes type (Type 1 vs Type 2 vs other specific types) based on age of onset, presence of ketoacidosis, autoantibody testing, and clinical presentation 2, 4
Detect existing diabetes complications including retinopathy, nephropathy, neuropathy, and cardiovascular disease 2, 1
Assess cardiovascular risk factors including blood pressure, lipid profile, and calculate 10-year atherosclerotic cardiovascular disease risk using the Pooled Cohort Equations 1, 5
Screen for autoimmune conditions in Type 1 diabetes patients, particularly thyroid dysfunction and celiac disease 2, 3
Establish baseline laboratory values including A1C, fasting lipid panel, liver function tests, serum creatinine with eGFR, spot urine albumin-to-creatinine ratio, and thyroid-stimulating hormone 6

Document the characteristics of diabetes onset: presence of diabetic ketoacidosis, degree of hyperglycemia, presence of symptoms (polyuria, polydipsia, weight loss), or asymptomatic laboratory finding 2, 4
Assess eating patterns and nutritional status: current diet, weight history, and readiness for behavior change 2, 4
Evaluate physical activity habits: current exercise patterns and barriers to activity 2, 4
Obtain family history: diabetes in first-degree relatives, cardiovascular disease, autoimmune conditions 2
Identify comorbid conditions: hypertension, dyslipidemia, obesity, psychosocial problems, depression, anxiety 2, 6

For Type 2 Diabetes with A1C ≥9%, the American Diabetes Association recommends starting dual therapy immediately with metformin and basal insulin 7
For Type 2 Diabetes with A1C <9% but ≥6.5%, initiate metformin and intensive lifestyle modification targeting 7% weight loss and 150 minutes weekly of moderate physical activity 7
For Marked Hyperglycemia with Ketoacidosis, initiate intravenous insulin immediately to correct hyperglycemia and metabolic derangement; once acidosis resolves, transition to subcutaneous insulin and start metformin 8

Assemble an interdisciplinary team including physicians, nurse practitioners, nurses, dietitians, pharmacists, and mental health professionals with diabetes expertise, with the patient assuming an active role in their care 2, 4
The management plan must be written collaboratively with input from the patient, family, physician, and care team 2, 4
Diabetes self-management education (DSME) and ongoing diabetes support are mandatory integral components of the initial management plan 2, 4

Provide focused education on glucose monitoring technique: proper use of glucometer, target ranges, and when to test 7
Educate on insulin injection technique (if applicable): proper injection method, systematic site rotation to prevent lipodystrophy 7
Teach hypoglycemia recognition and treatment: symptoms of low blood sugar and treatment with 15-20 grams of fast-acting carbohydrate 7
Emphasize medication adherence: importance of taking medications as prescribed 7
Discuss lifestyle modifications: specific dietary changes and physical activity recommendations 7

Administer age-appropriate vaccinations at the initial visit or schedule them promptly, including annual influenza vaccination for all patients ≥6 months of age 1, 5
Provide pneumococcal vaccination: PCV13 for children before age 2; PPSV23 for ages 2-64 years with diabetes; additional PPSV23 at age ≥65 regardless of vaccination history 1, 5
Offer Hepatitis B vaccine series (2-3 doses) for unvaccinated adults ages 18-59 years; consider for those ≥60 years 1, 5

Schedule follow-up visits every 3 months initially to assess medication tolerance, glycemic control, and treatment adherence 6
Check fasting blood glucose daily during insulin titration 7
Recheck A1C every 3 months until glycemic goals are achieved, then at least every 6 months 6
Monitor for hypoglycemia symptoms and adjust therapy accordingly 7
Assess medication-taking behavior, side effects, and barriers to adherence at each visit 1, 6

If A1C remains >7% after 3 months on metformin plus basal insulin, add prandial insulin or a GLP-1 receptor agonist, prioritizing agents with proven cardiovascular benefit for patients with established atherosclerotic cardiovascular disease 7
Consider adding an SGLT2 inhibitor or GLP-1 receptor agonist with cardiovascular benefit for patients with or at high risk for cardiovascular disease 7
For youth not meeting goals, maximize noninsulin therapies (metformin, GLP-1 receptor agonist, empagliflozin) before intensifying insulin 8

Do not delay dual therapy in patients with A1C ≥9%, as metformin monotherapy is insufficient 7
Do not use judgmental language such as "noncompliance" or "nonadherence"; use neutral, person-centered language that fosters collaboration 1, 5
Do not overlook screening for complications at the initial visit, as many patients have had undiagnosed diabetes for years 2, 1
Do not forget to assess psychosocial factors including depression, anxiety, and diabetes distress, which significantly impact self-management 1, 6